Literature DB >> 10378125

A primer on anaerobic bacteria and anaerobic infections for the uninitiated.

I Olsen1, C O Solberg, S M Finegold.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10378125     DOI: 10.1007/bf02561521

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  11 in total

1.  Anaerobic infections in humans: an overview.

Authors:  S M Finegold
Journal:  Anaerobe       Date:  1995-02       Impact factor: 3.331

Review 2.  Current issues and problems in dealing with anaerobes in the clinical laboratory.

Authors:  S D Allen; J A Siders; L M Marler
Journal:  Clin Lab Med       Date:  1995-06       Impact factor: 1.935

Review 3.  Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety.

Authors:  E J Goldstein
Journal:  Clin Infect Dis       Date:  1996-12       Impact factor: 9.079

Review 4.  Present studies of therapy for anaerobic infections.

Authors:  S M Finegold; H M Wexler
Journal:  Clin Infect Dis       Date:  1996-12       Impact factor: 9.079

5.  Microbiological examination of root canals and periapical tissues of human teeth. Methodological studies.

Authors:  A J Möller
Journal:  Odontol Tidskr       Date:  1966-12-20

6.  Short prereduced anaerobically sterilized (PRAS) biochemical scheme for identification of clinical isolates of bile-resistant Bacteroides species.

Authors:  D M Citron; E J Baron; S M Finegold; E J Goldstein
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

Review 7.  Current perspectives on anaerobic infections: diagnostic approaches.

Authors:  S M Finegold; H R Jousimies-Somer; H M Wexler
Journal:  Infect Dis Clin North Am       Date:  1993-06       Impact factor: 5.982

Review 8.  Clinical relevance of susceptibility testing of anaerobic bacteria.

Authors:  J E Rosenblatt; I Brook
Journal:  Clin Infect Dis       Date:  1993-06       Impact factor: 9.079

9.  Evaluation of an automated system for identification of anaerobic bacteria.

Authors:  A Arzese; R Minisini; G A Botta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-02       Impact factor: 3.267

Review 10.  Beta-lactam resistance in anaerobic bacteria: a review.

Authors:  M Hedberg; C E Nord
Journal:  J Chemother       Date:  1996-02       Impact factor: 1.714

View more
  5 in total

1.  In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.

Authors:  Reiner Schaumann; Matthias Funke; Eva Janssen; Arne C Rodloff
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

2.  gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.

Authors:  H Oh; N El Amin; T Davies; P C Appelbaum; C Edlund
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  Bacteroides fragilis group: trends in resistance.

Authors:  Manfred Fille; Monica Mango; Matthias Lechner; Reiner Schaumann
Journal:  Curr Microbiol       Date:  2006-01-31       Impact factor: 2.188

4.  Sixteen homologs of the mex-type multidrug resistance efflux pump in Bacteroides fragilis.

Authors:  Ohmi Ueda; Hannah M Wexler; Kaname Hirai; Yukinaga Shibata; Fuminobu Yoshimura; Setsuo Fujimura
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Anaerobic Bacteria in Clinical Specimens - Frequent, But a Neglected Lot: A Five Year Experience at a Tertiary Care Hospital.

Authors:  Padmaja Ananth Shenoy; Shashidhar Vishwanath; Ashwini Gawda; Seema Shetty; Renuka Anegundi; Muralidhar Varma; Chiranjay Mukhopadhyay; Kiran Chawla
Journal:  J Clin Diagn Res       Date:  2017-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.